END-STAGE LIVER DISEASE (ESLD)
Clinical trials for END-STAGE LIVER DISEASE (ESLD) explained in plain language.
Never miss a new study
Get alerted when new END-STAGE LIVER DISEASE (ESLD) trials appear
Sign up with your email to follow new studies for END-STAGE LIVER DISEASE (ESLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple drug make liver transplants safer? large trial underway
Disease control Recruiting nowThis study tests whether tranexamic acid, a drug that helps blood clot, can reduce blood loss during liver transplant surgery without causing dangerous clots. About 1,546 adults receiving a new liver will be randomly given either the drug or a placebo. The goal is to see if the d…
Matched conditions: END-STAGE LIVER DISEASE (ESLD)
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 26, 2026 06:24 UTC
-
Engineered immune cells aim to calm liver damage in first human trial
Disease control Recruiting nowThis study tests a new treatment called RTX001 for people with severe liver cirrhosis that has caused complications. RTX001 uses the patient's own immune cells (macrophages) that are modified in a lab to reduce inflammation and scarring in the liver. The trial will enroll 30 adul…
Matched conditions: END-STAGE LIVER DISEASE (ESLD)
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated May 11, 2026 20:40 UTC